Argatroban in adult extracorporeal membrane oxygenation

Journal of Extra-Corporeal Technology

Volumn 34, Issue 4, 2002, Pages 281-284

  Johnston, Nicklett ^a   Wait, Michael ^a   Huber, Lynne ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Activated partial thromboplastin time; Extracorporeal membrane oxygenation; Thrombin time; Thrombocytopenia

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; HEPARIN; THROMBIN INHIBITOR; ANTITHROMBIN; BIOMATERIAL; PIPECOLIC ACID DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; PARTIAL THROMBOPLASTIN TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; CHEMICALLY INDUCED DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; INSTRUMENTATION; UNITED STATES;

ADULT; ANTICOAGULANTS; ANTITHROMBINS; COATED MATERIALS, BIOCOMPATIBLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEPARIN; HUMANS; PIPECOLIC ACIDS; TEXAS; THROMBOCYTOPENIA;

EID: 0036987374     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Kawada T, Kitagawa G, Hoson M, Okada Y, Shiinyra J. Clinical application of Agatroban as an alternative anticoagulant for extracorporeal circulation. Blood Stasis Thromb. 2000;14:445-57.
2. Visentin G, Moghaddam M, Collins J, McFarland J, Aster R. Antibodies associated with heparin-induced thrombocytopenia report conformation changes in platelet factor four induced by linear, polyanionic compounds. Blood. 1997;90:460a.
3. Deitcher S. Heparin-induced thrombocytopenia: Pathogenesis, management, and prevention. Formulary. 2001;36:26-41.
4. Beyzarov E. Anticoagulant approved for heparin complication. Drug Topics. 2001;144:14-6.
5. Wallis L, Berkowitz S, Matthai W, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation. 2001;103:1838-46.
6. King P, Rosalion A, McMillan J, Buist M, Holmes P. Extracorporeal membrane oxygenation in pregnancy. Lancet. 2000;356:45-6.